Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas

Analysis of gene expression patterns in normal tissues and their perturbations in tumors can help to identify the functional roles of oncogenes or tumor suppressors and identify potential new therapeutic targets. Here, gene expression correlation networks were derived from 92 normal human lung samples and patient-matched adenocarcinomas. The networks from normal lung show that NKX2-1 is linked to the alveolar type 2 lineage, and identify PEBP4 as a novel marker expressed in alveolar type 2 cells. Differential correlation analysis shows that the NKX2-1 network in tumors includes pathways associated with glutamate metabolism, and identifies Vaccinia-related kinase (VRK1) as a potential drug target in a tumor-specific mitotic network. We show that VRK1 inhibition cooperates with inhibition of PARP signaling to inhibit growth of lung tumor cells. Targeting of genes that are recruited into tumor mitotic networks may provide a wider therapeutic window than that seen by inhibition of known mitotic genes.

[1]  Kam Y. J. Zhang,et al.  Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.

[2]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Stephen S. Taylor,et al.  Validating Aurora B as an anti-cancer drug target , 2006, Journal of Cell Science.

[4]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[5]  I Petersen,et al.  Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer , 2008, Oncogene.

[6]  H. K. Jeon,et al.  TERT promotes cellular and organismal survival independently of telomerase activity , 2008, Oncogene.

[7]  Ultan McDermott,et al.  Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma. , 2008, Cancer research.

[8]  P. N. Rao,et al.  Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.

[9]  Taebo Sim,et al.  Small Molecule Kinase Inhibitors Provide Insight into Mps1 Cell Cycle Function , 2010, Nature chemical biology.

[10]  A. Ochocka,et al.  FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53 , 2009, FEBS letters.

[11]  Ping Wang,et al.  Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genes. , 2007, American journal of respiratory cell and molecular biology.

[12]  J. Pignon,et al.  Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease. , 2007, The Cochrane database of systematic reviews.

[13]  R. Collins,et al.  Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. , 1997, JAMA.

[14]  Paolo Vineis,et al.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types , 2009, Nature Genetics.

[15]  Simon Heath,et al.  Lung cancer susceptibility locus at 5p15.33 , 2008, Nature Genetics.

[16]  M. Meyerson,et al.  TTF1 expression in non‐small cell lung carcinoma: association with TTF1 gene amplification and improved survival , 2009, The Journal of pathology.

[17]  Martin Kuiper,et al.  BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..

[18]  V. Capelozzi,et al.  Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma. , 2009, Lung cancer.

[19]  J. Lamb,et al.  Elucidating the murine brain transcriptional network in a segregating mouse population to identify core functional modules for obesity and diabetes , 2006, Journal of neurochemistry.

[20]  J. Simon,et al.  MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF‐β and pro‐inflammatory cytokines , 2005, Experimental dermatology.

[21]  J. Healey,et al.  Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Whitsett,et al.  Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. , 1999, Human pathology.

[23]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[24]  P. Lazo,et al.  The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein , 2000, Oncogene.

[25]  H. Varmus,et al.  Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain , 2005, PLoS medicine.

[26]  Elizabeth Iorns,et al.  A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor , 2008, The EMBO journal.

[27]  R. Doerge,et al.  Empirical threshold values for quantitative trait mapping. , 1994, Genetics.

[28]  A. Cohen.  Surgeons as an Integral Part of the Cancer Research Team , 2003, Cancer biology & therapy.

[29]  W. Hahn,et al.  Suppression of hPOT1 in Diploid Human Cells Results in an hTERT-Dependent Alteration of Telomere Length Dynamics , 2008, Molecular Cancer Research.

[30]  M. Polak,et al.  NKX2‐1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain‐Lung‐Thyroid Syndrome” , 2010, Human mutation.

[31]  Kai Wang,et al.  Meta-analysis of Inter-species Liver Co-expression Networks Elucidates Traits Associated with Common Human Diseases , 2009, PLoS Comput. Biol..

[32]  F. López-Ríos,et al.  Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas. , 2007, Lung cancer.

[33]  Rachel B. Brem,et al.  Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks , 2008, Nature Genetics.

[34]  M. Scavina,et al.  Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1. , 2004, The Journal of pediatrics.

[35]  C. Dang,et al.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.

[36]  A. Nobel,et al.  Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .

[37]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[38]  Matthew E. Ritchie,et al.  A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data , 2009, Nucleic acids research.

[39]  J. Nezu,et al.  Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. , 1997, Genomics.

[40]  P. Lazo,et al.  Human VRK1 Is an Early Response Gene and Its Loss Causes a Block in Cell Cycle Progression , 2008, PloS one.

[41]  E E Schadt,et al.  Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits , 2005, Nature Genetics.

[42]  Qiang Yu,et al.  Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control* , 2009, Journal of Biological Chemistry.

[43]  Paul S Mischel,et al.  Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells , 2008, Journal of neuroscience research.

[44]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[45]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[46]  R. Bast,et al.  Targeting Aurora kinases in ovarian cancer , 2006, Expert opinion on therapeutic targets.

[47]  M. Belvin,et al.  Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression. , 2009, Cancer research.

[48]  B. Chetaille,et al.  Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung , 2005, British Journal of Cancer.

[49]  Allan Balmain,et al.  Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility , 2011, Genome Biology.

[50]  D. V. Von Hoff,et al.  Targeting Aurora-2 kinase in cancer. , 2003, Molecular cancer therapeutics.

[51]  Derek Y. Chiang,et al.  Suppression of Lung Adenocarcinoma Progression by Nkx2-1 , 2011, Nature.

[52]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[53]  O. Rath,et al.  Regulation of human myoblast differentiation by PEBP4 , 2009, EMBO reports.

[54]  J. Dennis,et al.  Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis , 2005, Nature Genetics.

[55]  B. Comin-Anduix,et al.  The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations , 2010, Clinical Cancer Research.

[56]  Chung K. Chang,et al.  The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia , 2010, PLoS genetics.

[57]  G. Bepler,et al.  Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  P. Lazo,et al.  p53 Downregulates Its Activating Vaccinia-Related Kinase 1, Forming a New Autoregulatory Loop , 2006, Molecular and Cellular Biology.

[59]  Eric E. Schadt,et al.  Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits , 2005 .

[60]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[61]  W. Sellers,et al.  MEK1 mutations confer resistance to MEK and B-RAF inhibition , 2009, Proceedings of the National Academy of Sciences.